EIT Pharma is a biotechnology company focused on advancing therapies for infectious diseases with significant unmet medical needs. The company is developing a portfolio of programs designed to address serious infectious diseases through rigorous science, disciplined execution, and a patient-centered approach focused on translating scientific innovation into meaningful real-world impact for patients.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/03/26	$35,000,000	Series A	Arrowtown Good Ventures Propel Bio Partners	undisclosed